Integra LifeSciences Holdings (IART) is a publicly traded Healthcare sector company. As of May 21, 2026, IART trades at $15.22 with a market cap of $1.10B and a P/E ratio of -2.33. IART moved +7.06% today. Year to date, IART is +22.53%; over the trailing twelve months it is +15.54%. Its 52-week range spans $8.70 to $27.13. Analyst consensus is neutral with an average price target of $15.60. Rallies surfaces IART's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
IART financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. IART recently traded at $15.22. Market cap is $1.10B. P/E ratio is -2.33. Revenue is $1.64B.
| Metric | Value |
|---|---|
| Price | $15.22 |
| Market Cap | $1.10B |
| P/E Ratio | -2.33 |
| EPS | $-6.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.13 |
| 52-Week Low | $8.70 |
| Volume | 10 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.64B |
| Net Income | $-495.80M |
| Gross Margin | 51.94% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.64B | $-516.47M | $-6.74 |
| 2024 | $1.61B | $-6.94M | $-0.09 |
| 2023 | $1.54B | $67.74M | $0.85 |
| 2022 | $1.56B | $180.55M | $2.18 |
8 analysts cover IART: 0 strong buy, 1 buy, 4 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $15.60.